Qiagen Posts Q3 Profit Drop, Announces New Collaborations | GenomeWeb

SAN FRANCISCO, Oct. 29 – Qiagen on Monday reported a 14 percent drop in operating profits, which it said was a result of the Sept. 11 terrorist attacks on the United States.

The company saw a “significant rebound in sales beginning in early October” and expects continued strong growth in its sector, it said in a statement.

Earnings before interest and tax fell to $10.1 million from $11.8 million recorded in the same period one year ago, and net profit dipped to $6.2 million from $7.2 million, Qiagen said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.